Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Posts Tagged ‘disorder’

Quadrant Biosciences to Collaborate on Signature Study of Minocycline Treatment of Autism Spectrum Disorder

Posted by fidest press agency su sabato, 27 ottobre 2018

Quadrant Biosciences, Inc., an emerging life science company based in Syracuse, N.Y., today announced its collaboration with the Autism Speaks® Autism Treatment Network (ATN) and its university research partners on research into the treatment of autism spectrum disorder (ASD). The ATN is a collaboration of Autism Speaks and some of the finest children’s hospitals and academic institutions in North America, specializing in multi-disciplinary medical care for children with autism. This Signature Study, including researchers from the Cincinnati Children’s Hospital Medical Center, University of Pittsburgh, and University of Missouri, is looking at the treatment of autism symptoms with the antibiotic minocycline. In addition to providing financial support for this important study, Quadrant Biosciences will be collecting salivary RNA data to further its work on epigenetic factors associated with ASD.Prompted by earlier studies, researchers at the Cincinnati Children’s Hospital Medical Center initiated a study looking at the effects of minocycline treatment on ASD symptoms.
Given these characteristics, animal researchers hypothesized that minocycline treatment would improve autism symptoms, and indeed this was the case. Researchers saw improvement in many classic autism symptoms such as aberrant social interaction, exploratory behavior, locomotion, and anxiety behaviors in various mouse models of ASD treated with minocycline. Additionally, trials in humans with Fragile X Syndrome-associated ASD have demonstrated improvement on the Clinical Global Impression Improvement subscale. These compelling results prompted the initiation of the present Autism Speaks ATN Signature Study.
The Autism Speaks ATN research also received support through the ATN’s role as the federally funded Autism Intervention Research Network for Physical Health. The clinical trial to begin later this year will involve a 24-subject, double-blind, placebo-controlled, four-week crossover study of minocycline in youths with ASD ages 12 to 22 years. The study aims to: 1) Determine if minocycline use will be associated with reduction in elevated EEG gamma power in persons with ASD compared to placebo; 2) assess the short-term safety and tolerability of minocycline in youths with ASD; and 3) better understand the efficacy and dosage of minocycline for the short-term treatment of memory, social gaze, psychophysical markers, attentional impairments, quality of life, and other concerns in adolescents with ASD.
The study includes well-regarded researchers in the autism field including Craig A. Erickson, M.D., Professor, Division of Child and Adolescent Psychiatry, and Logan Wink, Associate Professor, Cincinnati Children’s Hospital Medical Center; David Beversdorf, M.D., Professor of Neurology, Radiology, and Psychology, Thompson Center for Autism & Neurodevelopmental Disorders, University of Missouri; and Benjamin Handen, Ph.D., Professor of Psychiatry, Pediatrics, Psychology, and Education, University of Pittsburgh.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Ilana Manolson: Untitled

Posted by fidest press agency su domenica, 31 Mag 2009

untitleNew York Jason McCoy Inc. 41 East 57th Street until 24/7/2009 Jason McCoy Gallery is pleased to present an exhibition of paintings by the Boston based artist Ilana Manolson. This will be the first New York solo exhibition for the artist. Ilana Manolson paints momentary impressions of nature as they unfold through the various seasons. Combining realist elements with fields of color abstraction, she depicts her subject on the verge of change and as it swings its pendulum between order and disorder. Having begun her career as a printmaker, who was used to adding “whites” through the omission of color, Manolson’s painting technique adds an interesting twist. Whereas traditionally a painter adds the lightest colors last, Manolson builds up paint to add highlights, but then employs a selection of spatulas and scrapers to “pull from the paint” and reveal the light that hides underneath it. Manolson is a former naturalist, whose work in a Canadian national park entailed the constant study of 12-inch squares of grazing land in order to assess the condition of the land at large. This experience has left her well equipped for the quest to transform microscopic details into representative images of the macrocosm. Here, changes of light and color or the illusive reflections found in water and sky, for example all become contemplations of transience and transformation, and Manolson adds: “Enter this painted place that creates its own logic: its order and rhythms; its contradictions and surprises. In these paintings we are part of an endless story of cycles -of seasons where in the comfort of repetition there is always something new…. Look down at your feet and you will see power in every neglected corner.” Ilana Manolson has exhibited extensively in the United States. She is a recent recipient of the Mass Cultural Council Grant (2008). Her works are in the permanent collections of the Museum of Fine Arts, Boston, the De Cordova Museum, Lincoln, the Boston Public Library, the Ballinglen Arts Foundation, JP Morgan & Company, New York; Sanford Bernstein & Sons, New York, and Citizens Bank, Providence, Rhode Island, among others. She lives and works in Boston. (image untitle)

Posted in Estero/world news, Mostre - Spettacoli/Exhibitions – Theatre | Contrassegnato da tag: , , , | Leave a Comment »